Sterling Capital Management’s Endocyte, Inc. Common Stock ECYT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q1 | – | Sell |
-30,273
| Closed | -$77K | – | 1036 |
|
|
2016
Q4 | $77K | Sell |
30,273
-385
| -1% | -$979 | ﹤0.01% | 944 |
|
|
2016
Q3 | $95K | Hold |
30,658
| – | – | ﹤0.01% | 890 |
|
|
2016
Q2 | $98K | Hold |
30,658
| – | – | ﹤0.01% | 906 |
|
|
2016
Q1 | $95K | Hold |
30,658
| – | – | ﹤0.01% | 888 |
|
|
2015
Q4 | $123K | Sell |
30,658
-3,888
| -11% | -$15.6K | ﹤0.01% | 956 |
|
|
2015
Q3 | $158K | Sell |
34,546
-11,100
| -24% | -$50.8K | ﹤0.01% | 932 |
|
|
2015
Q2 | $237K | Hold |
45,646
| – | – | ﹤0.01% | 829 |
|
|
2015
Q1 | $286K | Buy |
45,646
+34,886
| +324% | +$219K | ﹤0.01% | 798 |
|
|
2014
Q4 | $68K | Sell |
10,760
-4,756
| -31% | -$30.1K | ﹤0.01% | 903 |
|
|
2014
Q3 | $94K | Buy |
+15,516
| New | +$94K | ﹤0.01% | 883 |
|
|
2014
Q2 | – | Sell |
-29,667
| Closed | -$706K | – | 963 |
|
|
2014
Q1 | $706K | Buy |
+29,667
| New | +$706K | 0.01% | 686 |
|
|
2013
Q3 | – | Sell |
-23,125
| Closed | -$304K | – | 727 |
|
|
2013
Q2 | $304K | Buy |
+23,125
| New | +$304K | ﹤0.01% | 502 |
|